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Purpose: Adipose-derived stem cells (ADSC) are an abundant population of adult stem cells with the potential to
differentiate into several specialized tissue types, including neural and neural crest-derived cells. This study sought to
determine  if  ADSC  express  keratocyte-specific  phenotypic  markers  when  cultured  under  conditions  inducing
differentiation of corneal stromal stem cells to keratocytes.
Methods: Human subcutaneous adipose tissue was obtained by lipoaspiration. ADSC were isolated by collagenase
digestion and differential centrifugation. Side population cells in ADSC were demonstrated using fluorescence-activated
cell sorting after staining with Hoechst 33342. Differentiation to keratocyte phenotype was induced in fibrin gels or as
pellet cultures with serum-free or reduced-serum media containing ascorbate. Keratocyte-specific gene expression was
characterized using western blotting, quantitative RT–PCR, and immunostaining.
Results: ADSC contained a side population and exhibited differentiation to adipocytes and chondrocytes indicating adult
stem-cell potential. Culture of ADSC in fibrin gels or as pellets in reduced-serum medium with ascorbate and insulin
induced expression of keratocan, keratan sulfate, and aldehyde dehydrogenase 3 family, member A1 (ALDH3A1),
products highly expressed by differentiated keratocytes. Expression of differentiation markers was quantitatively similar
to corneal stromal stem cells and occurred in both serum-free and serum containing media.
Conclusions: ADSC cultured under keratocyte-differentiation conditions express corneal-specific matrix components.
Expression of these unique keratocyte products suggests that ADSC can adopt a keratocyte phenotype and therefore have
potential for use in corneal cell therapy and tissue engineering.
The cornea is the outermost tissue of the eye, providing
a protective barrier and a clear path for transmission and
refraction of light. This organ comprises three distinct cellular
layers: epithelium, stroma, and endothelium. The stroma is
primarily  responsible  for  the  strength  and  the  refractive
properties of the cornea [1]. The optical properties of the
stroma  result  from  layers  of  parallel  aligned  heterotypic
collagen fibrils composed of Types I and V collagen. This
collagen is associated with several proteoglycans from the
small leucine-rich (SLRP) family, including decorin, lumican,
keratocan, and mimecan (osteoglycin) [2-4]. The latter three
of  these  proteins  are  modified  with  long,  highly  sulfated
keratan  sulfate  glycosaminoglycan  comprising  the  corneal
keratan sulfate proteoglycans (KSPG), a family of molecules
unique to corneal stromal extracellular matrix (ECM). After
embryonic  development,  corneal  collagen  synthesis
decreases, but synthesis of the KSPGs is maintained at a high
level, suggesting an essential role for these ECM components
in homeostasis of stromal transparency. This role has been
confirmed by the loss of transparency associated with reduced
sulfated keratan sulfate [5,6] or the loss of keratan sulfate core
protein,  lumican  [7,8].  During  stromal  wound  healing,
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activated keratocytes transdifferentiate into fibroblasts and
myofibroblasts  and  deposit  ECM  with  reduced  corneal
KSPGs  and  a  corresponding  reduced  transparency  [9,10].
Similarly,  keratocytes  in  culture  rapidly  lose  KSPG
expression [11-14]. The corneal KSPGs, therefore, provide a
highly specific marker of keratocyte differentiation that is
closely  linked  with  the  ability  of  these  cells  to  maintain
corneal transparency.
Corneal  blindness  affects  8  million  individuals
worldwide, and currently corneal transplantation is the only
method of restoring corneal clarity and function to scarred
corneas. This procedure is not without limitations such as
immune rejection, graft failure, and limited access to donor-
quality tissue. In addition, those countries with the highest
rates of corneal blindness often do not have the infrastructure
to  treat  all  those  burdened  with  corneal  disease  [15].
Alternative approaches to transplantation to restore stromal
transparency have focused upon corneal tissue engineering
[16,17]  and  more  recently  stem  cell  therapy  [18,19].  The
difficulty in creating a successfully engineered cornea resides
in the requirement for a stromal equivalent that retains features
and components of the original stroma [18]. Cells to be used
for cell therapy and/or tissue engineering would ideally be
autologous and with the potential to secrete and organize
cornea-specific ECM without eliciting immune rejection.
Adipose-derived  stem  cells  (ADSC)  are  an  abundant
population of adult stem cells readily isolated from human
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2680adipose tissue. ADSC have multilineage potential and are able
to differentiate into fat, bone, cartilage, and muscle under
lineage-specific  culture  conditions  [20].  The  properties  of
ease of isolation, high cell yields, immunomodulation, and
multipotency  qualify  the  ADSC  as  an  ideal  source  of
autologous stem cells for cell therapy or tissue engineering of
corneal stroma.
We recently showed that adult stem cells derived from
corneal stroma can be expanded in vitro and can be induced
to adopt a keratocyte phenotype, secreting corneal KSPGs and
restoring transparency to disrupted corneas [18,21-35]. In this
study we investigated the ability of another adult stem cell
type, ADSC, to function as corneal stem cells in adopting
keratocyte phenotype in vitro. We were able to define culture
conditions  under  which  ADSC  were  induced  to  express
keratocan as well as high molecular weight keratan sulfate.
METHODS
Cells  and  materials:  Human  corneal  stromal  stem  cells
(CSSC)  and  corneal  fibroblasts  (CF)  were  isolated  and
cultured  as  previously  described  [21,23].  Briefly,  donor
human corneas not usable for transplantation were incubated
in 1.2 U/ml Dispase II (Roche Diagnostics, Pleasanton, CA)
overnight  at  4  °C.  Epithelial  and  endothelial  cells  were
removed by dissection and debridement, and the stroma was
minced into 2-mm cubes. Stromas were digested up to 3 h at
37  °C  in  Dulbecco’s  modified  Eagle’s  medium  (DMEM)
containing 1 mg/ml collagenase type L (Sigma-Aldrich, St.
Louis, MO). The resulting primary keratocytes were cultured
in a humidified atmosphere containing 5% CO2 in DMEM/
F-12  (Sigma-Aldrich)  with  antibiotics  [21]  for  one  week
before harvesting for RNA. Stem cells from the stromal digest
were expanded by culture at a density of 5×103 cells/cm2 in a
stem cell growth medium (SCGM) consisting of low glucose
DMEM:MCDB201 60:40 containing 2% fetal bovine serum
(FBS), 10 ng/ml epidermal growth factor (EGF), 10 ng/ml
platelet derived growth factor BB (PDGF), 5 ug/ml insulin, 5
ug/ml  transferrin,  5  ng/ml  selenium,  200  U/ml  LIF,  and
antibiotics/antimycotics [21]. Fibroblastic differentiation was
induced by 3 or more passages in DMEM/F-12 with 10% FBS.
Human subcutaneous adipose tissue was obtained from
patients  undergoing  elective  lipoaspiration  surgery  with
informed  consent  under  a  protocol  approved  by  the
Institutional  Review  Board  (IRB)  of  the  University  of
Pittsburgh, consistent with the principles of the Declaration
of  Helsinki.  Adipose-derived  stem  cells  were  isolated  by
collagenase  digestions  and  differential  centrifugation  as
previously  described  [24].  Primary  adipose-derived  cell
mixtures were cultured at 5×104 cells/cm2 in SCGM. When
the cells reached 80% confluency they were passaged 1:4
using trypsin. For flow cytometric analysis trypsizined ADSC
were incubated at 1×106 cells/ml in DMEM with 5 µg/ml
Hoechst 33342 dye for side population cell sorting [23] and
collected  for  further  culture.  Adipocyte  differentiation
medium contained DMEM with 17 µM D-pantothenic acid
(Sigma-Aldrich), 0.5 µM dexamethasone (Sigma-Aldrich),
0.2  nM  triiodothyronine  (Sigma-Aldrich),  and  1  µM
ciglitazone  (Enzo  Life  Sciences,  Plymouth  Meeting,  PA).
Chondrocyte  differentiation  was  induced  in  DMEM/
MCDB201,  2%  FBS,  0.1  mM  ascorbic  acid-2-phosphate,
10−7 M dexamethasone, 10 ng/ml recombinant transforming
growth factor beta 1 (TGFß1; Sigma-Aldrich) and 100 µg/ml
sodium pyruvate. Basal keratocyte differentiation medium
(KDM) contained Advanced DMEM (Invitrogen, Rockville,
MD) supplemented with 10 ng/ml fibroblast growth factor 2
(FGF2)  and  0.1  mM  ascorbic  acid-2-phosphate  (A2P).
Heparin-stripped, platelet-poor horse serum (HSHS) [13] was
added as noted. Bovine corneal extract in DMEM/F-12 as an
alternative to KDM was also used to compare keratocyte gene
expression  after  induction  [25].  Antibodies  used  included
anti-keratocan peptide antibody (KeraC) [11] and J19 or J36
monoclonal  antibodies  to  keratan  sulfate  [23].  Secondary
antibodies  for  western  blotting,  peroxidase-labeled  anti-
mouse  and  anti-rabbit  IgG,  were  from  Santa  Cruz
Biotechnology (Santa Cruz, CA). For fluorescence staining,
Alexa  Fluor  488  anti-mouse  IgG  and  anti-rabbit  IgG  and
nuclear dye TO-PRO-3 were obtained from Invitrogen.
Side population cell sorting: ADSC were isolated as a side
population  on  a  high-speed  cell  sorter  (MoFlo;
DakoCytomation, Fort Collins, CO) using 350 nm excitation
and 450nm emission in a method similar to that previously
described for corneal stromal stem cells [23]. Verapamil was
added to validate side population isolation. After sorting, side
population cells were cloned by limiting dilution, maintained
TABLE 1. RT–PCR PRIMERS.
Gene Name Gene ID Primer sequence
Leptin NM_000230 Forward: TCCTGGATTCCTTTCCTTCA
    Reverse: CAATCGAGGAGGGCAGAATA
Keratocan NM_007035 Forward: ATCTGCAGCACCTTCACCTT
    Reverse: CATTGGAATTGGTGGTTTGA
ALDH3A1 NM_001135168 Forward: CATTGGCACCTGGAACTACC
    Reverse: GGCTTGAGGACCACTGAGTT
18S Ribosomal RNA NR_003286 Forward: CCCTGTAATTGGAATGAGTCCAC
    Reverse: GCTGGAATTACCGCGGCT
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2681in stem cell growth medium (SCGM) and passaged 1:3 by
trypsinization when subconfluent.
Pellet  and  fibrin  gel  culture:  For  pellet  culture,  2×105
passage-4 ADSC were collected in a conical bottom 15-ml
tube and centrifuged at 400× g for 5 min to form a pellet. The
pellets were cultured in SCGM for 3 days, then transferred
into various differentiation media which were changed every
3  days  for  up  to  3  weeks.  For  fibrin  gel  culture,  33  µl
suspension of 12×106 cells/ml passage-4 ADSC were seeded
into a fibrin gel consisting of 134 µl of 5 mg/ml human
fibrinogen (Sigma-Aldrich) and 33 µl of 100 U/ml bovine
thrombin (Sigma-Aldrich). The gel formed in a cell culture
Figure 1. Flow cytometric identification
of side population from cultured human
adipose-derived stem cells (ADSC). A:
Passage-two  ADSC  stained  with
Hoechst  33342  were  analyzed  using
350-nm excitation with blue (635 nm)
and  red  (488  nm)  emission.  Cells
showing reduction of both blue and red
fluorescence  (side  population  cells)
were  analyzed  as  defined  by  the  box
outlined    on    the    left.    B:       An
analysis  similar  to  (A)  but  with  a
preincubation  in  50  μM  verapamil
before incubation with Hoechst 33342.
Figure 2. Induction of adipocytes from
ADSC.  ADSC  were  induced  to
differentiate into adipocytes in ADM for
two weeks as described in Methods. A,
B: ADSC were fixed and stained with
Oil  Red  O.  C,  D:  ADSC  without
induction were stained with Oil Red O
as  control.  E:  mRNA  for  leptin  was
detected by RT–PCR. Leptin expression
(Upper)  and  18S  (Lower).  Lane  1,
uncultured keratocytes; lane 2, ADSC;
lane  3,  ADSC  in  adipocyte  induction
medium. Scale bars: 100 μm (A, C); 50
μm (B, D).
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2682incubator (37 °C, 5% CO2) for 1 h, and then SCGM containing
1 mg/ml ε-amino-N-caproic acid (Sigma-Aldrich) was added
for 3 days. The medium was replaced with KDM containing
ε-amino-N-caproic  acid  at  day  3  and  changed  at  3-day
intervals. Human corneal fibroblasts (CF) [18] were used as
control for pellet culture and fibrin gel culture. The CF were
cultured under the same conditions as ADSC. Media were
collected for western blot to detect the expression of keratocan
and  keratan  sulfate  after  ion  exchange  isolation  of
proteoglycans (described below). Cells from the same cultures
were lysed to make RNA for RT–PCR or quantitative PCR or
were fixed for immunostaining.
Quantitative RT–PCR (qPCR): Cell pellets and cells in fibrin
gels  were  stored  in  a  stabilizing  reagent  (RNAlater;
Invitrogen, Austin, TX) for 1 day. RNA was then isolated
using  the  RNeasy  mini  kit  (Qiagen,  Valencia,  CA)  [23],
treated with DNase I (Invitrogen) and concentrated by alcohol
precipitation. cDNA was transcribed from the RNA using
SuperScript II reverse transcriptase (Invitrogen), following
recommendations of the manufacturer. qPCR of cDNA was
performed using assays containing fluorescent hybridization
probes (TaqMan; Applied Biosystems, Foster City, CA) or
with direct dye binding (SYBR Green; Applied Biosystems)
as previously described [21]. Primers for SYBR assays were
designed using online software (Primer 3) with the sequences
shown in Table 1. Amplification of 18S rRNA was performed
for  each  cDNA  (in  triplicate)  for  normalization  of  RNA
content. A negative control lacking cDNA was also included
in each assay. Relative mRNA abundance was calculated as
the Ct for amplification of a gene-specific cDNA minus the
average Ct for 18S expressed as a power of 2 (2–ΔΔCt). Three
individual gene-specific values thus calculated were averaged
to obtain mean±SD.
Western blotting: Proteoglycans were recovered from culture
media by ion exchange chromatography on microcolumns
(SPEC-NH2;  Agilent  Technologies,  Wilmington,  DE),  as
described previously [23]. Proteoglycans were digested with
a  mixture  of  keratanase  II  and  endo-β-galactosidase  [13].
Digested and undigested samples were run on a 4%–20%
SDS–PAGE  gel,  transferred  to  polyvinylidene  difluoride
(PVDF) membrane and subjected to immunoblotting with
KeraC  antibody  against  keratocan  [13]  and  antibody  J36
against keratan sulfate [21].
Histology: Monolayer cells were rinsed briefly in phosphate-
buffered  saline  (PBS),  fixed  for  12–15  min  in  3%
paraformaldehyde in PBS at room temperature, and rinsed in
PBS. Oil red O (Sigma-Aldrich) was prepared at 0.5% in
isopropanol, diluted to 0.3% in water and filtered before use.
Cells were stained with oil red O for 15 min and rinsed with
60% isopropanol followed by hematoxylin stain for nuclei.
Bright-field  micrography  was  performed  with  a  40×  oil
objective. Pellets and fibrin gels were rinsed briefly in PBS,
fixed for 15 min in 3% PFA in PBS at room temperature,
rinsed  in  PBS,  embedded  in  optimal  cutting  temperature
embedding  compound  (Tissue-Tek  OCT;  Electron
Microscopy Sciences, Hatfield, PA), frozen, and stored at
−20 °C until they were cut as 8-µm sections on a cryostat.
Sections were hydrated in PBS before staining. Nonspecific
binding was blocked with 10% heat-inactivated goat serum.
Sections were incubated for 1 h at room temperature with
primary  antibodies.  After  two  rinses  in  PBS,  secondary
antibodies and nuclear counterstain (TO-PRO-3; Invitrogen)
were added for 1 h at room temperature. The samples were
Figure 3. Induction of cartilage matrix
expression by ADSC. ADSC (A) and
CF (B) were cultured as pellets (2×105)
in chondrocyte differentiation medium
for three weeks. The pellets were fixed,
imbedded in OCT, cut into 8 µm thick
sections and stained with toluidine blue
to detect proteoglycan staining typical
of cartilage. Scale bar indicates 50 μm.
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2683photographed using a confocal microscope with a 20× oil
objective (Bio-Rad Laboratories, Hercules, CA).
RESULTS
Side population cells in ADSC: Human ADSC isolated by
collagenase and differential centrifugation were labeled with
Hoechst 33342 dye and analyzed using flow cytometry to
identify  side  population  cells  (Figure  1).  This  technique
originally described by Goodell et al. [26] identifies cells that
efflux the Hoechst 33342 dye as a result of the expression of
ATP-binding  cassette  (ABC)  transporter  proteins.  Side
population cells are present in small numbers in many tissues
and have been found to exhibit adult stem cell-like properties
[27,28]. Figure 1A demonstrates that a population (defined by
the box) amounting to less than 1% of the total cells shows
reduced Hoechst 33342 dye staining and a color shift toward
blue  in  the  cultured  ADSC.  When  we  preincubated  with
verapamil,  an  inhibitor  of  ABC  transporter  function,  the
population was eliminated (Figure 1B). The presence of this
characteristic  side  population  suggests  the  presence  of
multipotent adult stem cells in the ADSC [27,28].
Differentiation  potential  of  ADSC:  To  demonstrate
multipotent differentiation potential, ADSC were expanded
and grown in under conditions that induce differentiation to
mature adipocytes in adult stem cells. Figure 2A,B shows
staining with oil red O, which stains the characteristic neutral
triglycerides  and  lipids  in  adipocytes.  Well  defined  lipid
droplets were present within differentiated cells. Figure 2C,D
shows the lack of oil red O staining in ADSC cultured in
SCGM. Expression of the leptin gene encoding an adipokine
Figure  4.  Induction  of  keratocyte
markers in ADSC. A, B: ADSC were
cultured in fibrin gels for 3 weeks in
keratocyte  differentiation  medium.  C,
D: ADSC were cultured as pellet for 3
weeks  in  keratocyte  differentiation
medium.  Immunofluorescent  staining
shows the presence of keratan sulfate
with  antibody  J19  (green;  A,  C)  or
keratocan with antibody KeraC, (green;
B, D). Red shows nuclear staining by
propidium iodide. E: RT–PCR shows
keratocan expression in (left to right)
uncultured  keratocytes  (positive
control), ADSC in fibrin gel, ADSC as
pellet culture, ADSC in SCGM. Scale
bars=20 μm.
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2684secreted by mature adipocytes [29] was increased in ADSC
after  culture  in  ADM  (Figure  2C).  Leptin  was  minimally
expressed by keratocytes, but was upregulated in multipotent
stromal corneal stem cells as well as in ADSC.
ADSC were also cultured under conditions reported to
induce  chondrogenic  differentiation.  After  3  weeks  in
chondrocyte differentiation medium, as shown in Figure 3A,
ADSC  secreted  cartilage  matrix  as  indicated  by  positive
toluidine  blue  staining  for  proteoglycans  characteristic  of
cartilage [30]. In contrast, CF grown in pellet culture did not
display chondrogenic differentiation as evidenced by absence
of toluidine blue staining (Figure 3B).
Expression of keratocyte markers: Given the clear multipotent
nature of ADSC, we investigated the ability of these cells to
assume  a  keratocyte  phenotype  using  methods  previously
successful in differentiating human corneal stromal stem cells
into keratocytes [21]. ADSC were seeded in fibrin gels (Figure
4A,B) and cultured as pellets (Figure 4C,D) and transferred
into KDM for 3 weeks. Immmunostaining of ADSC cultures
the showed presence of the stroma-specific ECM molecules
keratocan and keratan sulfate in both the fibrin gels and pellets
(Figure 4). ADSC in fibrin gels were more sparsely distributed
(Figure  4A,B)  than  in  the  pellet  cultures  (Figure  4C,D).
Expression of keratocan in ADSC incubated in KDM was
confirmed  with  RT–PCR  using  human  keratocan  primers
(Figure  4E).  ADSC  maintained  in  SCGM  alone  did  not
express  keratocan  mRNA.  In  addition,  we  observed  (not
shown)  that  ADSC  in  KDM  formed  extensive  cell-cell
contacts  similar  to  those  connecting  keratocytes.  Cultures
using  both  fibrin  gel  and  pellet  methods  induced  ADSC
differentiation into keratocyte-like cells.
Figure  5.  Keratan  sulfate,  keratocan
protein,  and  mRNA  expression  by
CSSC,  ADSC,  and  CF  in  different
media. A, B: Fibrin gel cultures after 3
weeks.  C,  D:  Pellet  cultures  after  3
weeks.  A  and  C  are  western  blots
showing keratan sulfate and keratocan.
B and D show qPCR data of keratocan
mRNA. Samples 1–3: CF, 4–6: CSSC
cells; 7–9, ADSC cells. Samples 1, 4, 7:
keratocyte  differentiation  medium;
Samples  2,  5,  8:  keratocyte
differentiation  medium  +  1%  HSHS.
Samples 3, 6, 9: DMEM/F-12 medium
with bovine corneal extract (1:10) [25].
Expression  of  mRNA  is  shown
normalized to monolayer of CSSC in
keratocyte differentiation medium=100.
Figure  6.  ALDH  is  upregulated  in
ADSC  cultured  under  conditions  that
induce  keratocyte  differentiation.
Expression  of  ALDH3A1  was
compared  in  ADSC  cells  cultured  as
described in Figure 5 using qPCR as
described in Methods. Expression levels
were  normalized  to  that  of  ADSC  in
SCGM  (ADSC-Ctrl)  in  samples  in
Fibrin or Pellets under conditions 7, 8, 9
as described in Figure 5.
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2685After  we  established  the  differentiation  potential  of
ADSC into cells synthesizing keratocyte-specific proteins, we
examined the effects of varying culture conditions on both
keratocan  and  keratan  sulfate  expression  levels.  Using  a
combination of three different culture media and fibrin gel or
pellet culture, we found that ADSC in pellet cultures (Figure
5C,D) had more consistent expression of both keratocan and
keratan sulfate at the protein and mRNA level than ADSC in
fibrin gels (Figure 5A,B). This was similar to human CSSC,
which have elevated keratocan expression in pellet cultures
compared to fibrin gel culture (Figure 5A,B) [21]. In fact, the
level of keratocan mRNA in ADSC in pellet culture was
similar to that of stem cells from corneal stroma (CSSC;
Figure 5D). Bovine corneal extract [25] appeared to enhance
differentiation of the ADSC but had little effect on CSSC
(Figure 5, samples 6 and 9).
The gene ALDH3A1 codes for the widely distributed
protein aldehyde dehydrogenase (ALDH).  In differentiated
cells  of  the  cornea,  however,  ALDH  is  exceptionally
abundant, especially in keratocytes, where it makes up as
much as 40 % of soluble protein [31]. Previously we observed
ALDH to be markedly upregulated as CSSC differentiate to
keratocytes [21] thus, we would expect ALDH upregulation
if ADSC are adopting keratocyte phenotype. In Figure 6 we
documented  strong  upregulation  of  this  corneal  marker
mRNA, particularly in the pellet cultures of ADSC.
Immunostaining  of  keratan  sulfate  (Figure  7)  and
keratocan (Figure 8) demonstrated that the mRNA increases
documented in Figure 5 correlate with accumulation of these
keratocyte-specific  markers  in  the  ECM  of  the  cultures.
Consistent with mRNA levels, accumulation of these matrix
molecules was more evident in pellet cultures, and CSSC and
ADSC generated similar amounts. This result was in contrast
to  CF  which  did  not  consistently  synthesize  keratocan  or
keratan sulfate when grown in either fibrin gels or pellets.
DISCUSSION
In  this  study  we  have  shown  that  ADSC  isolated  from
lipoasiprate have the potential to differentiate in vitro into
cells that synthesize and secrete keratocyte-specific proteins
as confirmed by both immunohistochemical and molecular
evidence. Throughout our study we used ADSC grown and
expanded  at  clonal  density.  These  cells  were  cultured  in
various  differentiation  conditions  while  maintaining  their
ability  to  differentiate  into  adipocyte  (Figure  2)  and
chondrocyte (Figure 3) lineages similar to results reported
previously [32]. In addition, we show that ADSC grown in
three-dimensional  fibrin  gel  and  pellet  culture  systems
supplemented with appropriate differentiation medium can be
induced to differentiate into a keratocyte lineage (Figure 4,
Figure 5, and Figure 6). This differentiation is evidenced by
the  high  levels  of  cornea-specific  keratocan  mRNA  and
protein  expression  and  the  increased  presence  of  keratan
sulfate  in  the  culture  medium.  Expression  of  aldehyde
Figure 7. Keratan sulfate staining in CSSC, ADSC, and CF cultured in fibrin gels or as pellets in different media. Frozen sections of pellet
and fibrin gel cultures were stained with antibody J19 against keratan sulfate (green) and nuclei (red) after 3 weeks of culture in different
media. Abbreviations: CSSC: corneal stromal stem cells, ADSC: Adipose-derived stem cell, Adv: Advanced DMEM, FGF: fibroblast growth
factor 2, HS: heparin stripped horse serum, CE: bovine corneal extract. Scale bars=50 μm.
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2686dehydrogenase  3  family,  member  A1  (ALDH3A1),
keratocan, and keratan sulfate by ADSC was observed in
several different media and in both culture formats.
Our previous work showed that keratan sulfate is 103- to
106 fold more enriched in cornea than any other tissue [33]
and that synthesis of keratan sulfate by keratocytes is highly
regulated  in  vitro  and  in  vivo  [14,34,35].  Keratan  sulfate
biosynthesis in vitro, therefore, represents the most stringent
marker  of  the  keratocyte  phenotype  yet  described.  The
observation that ADSC can be induced to produce keratan
sulfate is novel and presents the best evidence to date that
these cells can adopt the keratocytes phenotype. Keratocan is
highly enriched in keratocytes, as is ALDH3A1. Neither of
these proteins represents a unique corneal marker but like
keratan sulfate, both, are highly expressed in keratocytes and
upregulated  as  CSSC  differentiate  to  keratocytes  [21].
Upregulation  of  keratocan  and  ALDH3A1  mRNA
simultaneously with synthesis of keratan sulfate by ASSC
strengthens  the  argument  that  these  cells  are  indeed
differentiating to keratocytes.
High cell density, as occurs in pellet cultures, rather than
dendritic cell morphology, appeared to positively influence
keratocyte  differentiation  potential.  The  pellet  cultures
produced  a  denser,  more  abundant  ECM  with  higher
keratocan and keratan sulfate. This is similar to what we
observed in human CSSC, which differentiate and express
higher levels of keratocan and keratan sulfate in pellet cultures
[21,36]. Compared to fibrin gels, ADSC expressed higher
keratocan and keratan sulfate in pellet cultures (Figure 5).
Although  pellet  cultures  clearly  influenced  keratocan
expression, the addition of extra supplementary factors such
as  horse  serum  and  bovine  extract  did  not  appear  to
significantly  enhance  levels  of  keratocan  protein.  Thus,
keratocyte  differentiation  of  ADSC  appears  to  be  more
dependent on the three-dimensional culture environment and
less  dependent  on  exogenous  molecular  supplementation.
Growth of differentiated keratocytes based on the architecture
of the culture conditions, rather than a complicated menu of
biologically active molecules, may be advantageous to the
future isolation and production of clinically useful cells while
lowering the risk of contaminants from additions.
ADSC are an abundant and readily accessible source of
multipotent adult stem cells with the desirable potential for
autologous cell therapy, thereby presenting the potential for
personal tissue engineering of the corneal stroma. A recent
study  by  Arnalich-Montiel  et  al.  [19]  demonstrated  that
human lipoaspirate-derived cells could be transplanted into
the corneal stroma of rabbits. Under these conditions, the
ADSC did not elicit a significant immune response, remained
viable, and could be immunostained for ALDH and keratocan
[19]. The current study builds on these findings, using the
more stringent keratocyte phenotypic marker keratan sulfate
and defining in vitro conditions under which the keratocyte
phenotype is expressed by these cells. Understanding these
conditions will allow development of use of ADSC in stromal
bioengineering applications.
Figure 8. Keratocan staining in CSSC, ADSC, and CFs cultured in different media. Frozen sections of pellet and fibrin gel cultures were
stained with antibody KeraC for keratocan (green) and cell nuclei (red) after 3 weeks of culture in several different media. Abbreviations:
CSSC: corneal stromal stem cells, ADSC: Adipose-derived stem cell, Adv: Advanced DMEM, FGF: fibroblast growth factor 2, HS: heparin
stripped horse serum, CE: bovine corneal extract. Scale bar=50 μm.
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important aspect of their potential use in cell based therapy.
These  effects  have  been  attributed  to  a  lack  of  HLA-DR
expression and active suppression of the proliferative T-cell
response [37]. ADSC have been shown to enhance dermal
wound healing by the secretion of a variety of soluble growth
factors accelerating wound repair and regeneration [38]. In
addition,  ADSC  were  shown  to  increase  wound  healing
through differentiation into cell types capable of replacing and
regenerating damaged tissue [39]. The biologic effect these
soluble  factors  have  in  corneal  wounds  remains  to  be
determined, but could include production of the correct ECM
and  maintenance  of  a  keratocyte  phenotype.  Particularly
relevant to the environmental exposures of the cornea, ADSC
have been shown to provide protective antioxidant effects
against  chemically-  and  UVB-induced  reactive  oxygen
species [40,41].
Athough  KSPGs  and  ALDH  are  markers  of  the
keratocyte phenotype, the true test of keratocyte function is
elaboration of the highly organized, transparent ECM of the
corneal stroma. Thus, the potential for ADSC in corneal cell
therapy  and  tissue  engineering  will  require  further
examination before clinical application. Our previous work
identifying the molecular markers for keratocytes [21,23] will
allow  us  to  determine  how  far  along  the  differentiation
pathway the ADSC have traveled. It will be important to
determine the long-term fate of ADSC-derived keratocyte-
like cells and the surrounding stromal cells. ADSC have the
potential to secrete many molecules that may influence wound
healing in a manner detrimental to corneal transparency.
In  conclusion,  our  results  provide  novel  evidence
documenting the potential of ADSC to adopt a keratocyte
phenotype  in  vitro.  These  results  confirm  and  extend  the
results of an earlier in vivo study [19]. Although more detailed
molecular  characterization  of  the  tissue  elaborated  by  the
ADSC will be necessary, the demonstration that non-ocular
adult stem cells have potential to generate corneal ECM in
vitro  opens  an  important  potential  for  bioengineering  of
corneal tissue using autologous cells.
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